Growth Metrics

Legend Biotech (LEGN) Gross Margin (2019 - 2025)

Legend Biotech (LEGN) posted Gross Margin of 79.04% for Q4 2025, down 2.04% on a QoQ basis from 80.68% in Q3 2025, and up 526.0% year-over-year from 12.63% in Q4 2024.

Legend Biotech (LEGN) has 7 years of Gross Margin data on file, last reported at 79.04% in Q4 2025.

  • In Q4 2025, Gross Margin rose 526.0% year-over-year to 79.04%; the TTM figure through Dec 2025 stood at 79.99% (up 350.0% YoY), while the FY2025 annual figure was 80.0%, up 351.0% from the prior year.
  • Gross Margin eased to 79.04% in Q4 2025, from 80.68% in the prior quarter.
  • Across five years, Gross Margin topped out at 100.0% in Q4 2023 and bottomed at 97963.15% in Q1 2021.
  • A 5-year average of 4855.39% and a median of 71.57% in 2023 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2021 — Gross Margin sank 9800646 bps — and 2022, when it soared 9802058 bps.
  • Year by year, Gross Margin stood at 35.43% in 2021, then jumped by 118 bps to 6.55% in 2022, then surged by 1427 bps to 100.0% in 2023, then decreased by 26 bps to 73.78% in 2024, then rose by 7 bps to 79.04% in 2025.
  • The last three Gross Margin figures came in at 79.04% (Q4 2025), 80.68% (Q3 2025), and 81.16% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 79.04%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 86.85%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 91.79%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 82.22%
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 79.04%
Sep 30, 2025 80.68%
Jun 30, 2025 81.16%
Mar 31, 2025 79.00%
Dec 31, 2024 73.78%
Sep 30, 2024 72.37%
Jun 30, 2024 83.88%
Mar 31, 2024 74.23%
Dec 31, 2023 100.00%
Sep 30, 2023 78.03%
Jun 30, 2023 70.78%
Mar 31, 2023 50.59%
Dec 31, 2022 6.55%
Sep 30, 2022 31.10%
Jun 30, 2022 -129.22%
Mar 31, 2022 57.43%
Dec 31, 2021 -35.43%
Sep 30, 2021 -15.70%
Jun 30, 2021 17.06%
Mar 31, 2021 -97,963.15%
Dec 31, 2020 40.71%
Sep 30, 2020 20.94%
Jun 30, 2020 17.61%
Mar 31, 2020 43.31%
Dec 31, 2019 31.24%
Sep 30, 2019 74.77%
Jun 30, 2019 50.13%